Literature DB >> 1747700

Primary Sjögren's syndrome in north east England--a longitudinal study.

C A Kelly1, H Foster, B Pal, P Gardiner, A J Malcolm, P Charles, G S Blair, J Howe, W C Dick, I D Griffiths.   

Abstract

We have documented the initial clinical features of 100 patients with primary Sjögren's syndrome (SS) together with the results of their baseline investigations. The evolution of the disease in these patients has been followed for a median of 34 months (range 3-84 months). The majority of patients were females aged 40-60 years, and common clinical features included eye symptoms (100%), xerostomia (100%), polyarthralgia (94%), Raynaud's phenomenon (81%) and salivary gland swelling (47%). Thyroid disease was relatively common (14%) while other endocrine disease was rare. Four patients died during follow-up, and three cases of lymphoma were detected. Other serious complications included pericarditis (10%), pleuroparenchymal lung disease (9%), renal tubular acidosis (3%) and cerebrovascular accidents (2%). The presence of anti-Ro antibodies identifies patients with more severe systemic disease. Spontaneous improvement occurred in 12 patients, while steroids were required for specific complications in 18. Overall, although lymphoma was found to excess in our group, the high mortality reported with primary SS elsewhere was not seen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747700     DOI: 10.1093/rheumatology/30.6.437

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  13 in total

1.  Lymphocytic alveolitis: A surprising index of poor prognosis in patients with primary Sjogren's syndrome.

Authors:  Y A Dalavanga; P V Voulgari; A N Georgiadis; C Leontaridi; S Katsenos; M Vassiliou; A A Drosos; S H Constantopoulos
Journal:  Rheumatol Int       Date:  2005-12-13       Impact factor: 2.631

2.  A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects.

Authors:  M Pertovaara; E Pukkala; P Laippala; A Miettinen; A Pasternack
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

3.  Active immunological profile is associated with systemic Sjögren's syndrome.

Authors:  Clothilde Martel; Guillaume Gondran; David Launay; Fabrice Lalloué; Sylvain Palat; Marc Lambert; Kim Ly; Veronique Loustaud-Ratti; Holly Bezanahary; Eric Hachulla; Marie Odile Jauberteau; Elisabeth Vidal; Pierre Yves Hatron; Anne Laure Fauchais
Journal:  J Clin Immunol       Date:  2011-07-09       Impact factor: 8.317

4.  Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both).

Authors:  M Pertovaara; M Korpela; H Uusitalo; J Pukander; A Miettinen; H Helin; A Pasternack
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

5.  Autoimmune thyroiditis and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.

Authors:  R Tunc; M S Gonen; O Acbay; V Hamuryudan; H Yazici
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

6.  Leucocytoclastic vasculitis as presenting feature of primary Sjögren's syndrome.

Authors:  H M Markusse; M Schoonbrood; M Oudkerk; S C Henzen-Logmans
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

7.  Respiratory disease in systemic lupus erythematosus: correlation with results of laboratory tests and histological appearance of muscle biopsy specimens.

Authors:  S A Evans; N D Hopkinson; W J Kinnear; L Watson; R J Powell; I D Johnston
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

Review 8.  Thyroid disease in Sjögren's syndrome.

Authors:  Luis J Jara; Carmen Navarro; María del Pilar Brito-Zerón; Mario García-Carrasco; Ricardo O Escárcega; Manuel Ramos-Casals
Journal:  Clin Rheumatol       Date:  2007-06-09       Impact factor: 2.980

9.  Distribution of CXCR3- or CCR4-positive cells in interstitial pneumonia associated with primary Sjogren's syndrome.

Authors:  Shigeki Shimizu; Takeo Yoshinouchi; Taio Naniwa; Mikae Nakamura; Shigeki Sato; Yuji Ohtsuki; Jiro Fujita; Ichiro Yamadori; Tadaaki Eimoto; Ryuzo Ueda
Journal:  Virchows Arch       Date:  2004-09-10       Impact factor: 4.064

10.  Autoantibody to NA14 is an independent marker primarily for Sjogren's syndrome.

Authors:  Kazuhisa Nozawa; Keigo Ikeda; Minoru Satoh; Westley H Reeves; Carol M Stewart; Yueh-Chun Li; Tim J Yen; Rosa M Rios; Kenji Takamori; Hideoki Ogawa; Iwao Sekigawa; Yoshinari Takasaki; Edward K L Chan
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.